Showing results (1771-1780 of 2,227) with videos related to
Sort By:
Pageof 223
Handbook of Experimental Pharmacology|April 13, 2011
Targeting type 2 diabetesChristina Schwanstecher, Mathias SchwanstecherHandbook of Experimental Pharmacology|April 13, 2011
Overcoming insulin resistance with ciliary neurotrophic factorTamara L Allen, Vance B Matthews, Mark A FebbraioHandbook of Experimental Pharmacology|April 13, 2011
AMP-activated protein kinase and metabolic controlBenoit Viollet, Fabrizio AndreelliHandbook of Experimental Pharmacology|April 13, 2011
Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspectsFranz M Matschinsky, Bogumil Zelent, Nicolai M Doliba, et al.Handbook of Experimental Pharmacology|June 23, 2011
Phosphodiesterase inhibitors: factors that influence potency, selectivity, and actionSharron H Francis, Miles D Houslay, Marco ContiHandbook of Experimental Pharmacology|June 23, 2011
Pharmacology, clinical efficacy, and tolerability of phosphodiesterase-4 inhibitors: impact of human pharmacokineticsHermann Tenor, Armin Hatzelmann, Rolf Beume, et al.Handbook of Experimental Pharmacology|June 23, 2011
A fission yeast-based platform for phosphodiesterase inhibitor HTSs and analyses of phosphodiesterase activityDidem Demirbas, Ozge Ceyhan, Arlene R Wyman, et al.Handbook of Experimental Pharmacology|June 23, 2011
Phosphodiesterase inhibition in heart failureMatthew A Movsesian, Rakesh C KukrejaHandbook of Experimental Pharmacology|June 23, 2011
Treatment of erectile dysfunction and lower urinary tract symptoms by phosphodiesterase inhibitorsStefan Uckert, Christian G StiefHandbook of Experimental Pharmacology|June 23, 2011
Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophyJustin M Percival, Candace M Adamo, Joseph A Beavo, et al.Pageof 223